Eton Pharmaceuticals Inc. (ETON)
NASDAQ · Healthcare
Eton Pharmaceuticals Inc. EBITDA 2019–2025
Eton Pharmaceuticals Inc. annual/quarterly ebitda history and growth rate from 2019 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Eton Pharmaceuticals Inc. ebitda for the quarter ending March 31, 2026 was 3.5 M, a 552.85% increase year-over-year.
- Eton Pharmaceuticals Inc. ebitda for the twelve months ending March 31, 2026 was 1.2 M, a 107.96% decrease year-over-year.
- Eton Pharmaceuticals Inc. annual ebitda for 2025 was 3.2 M, a 320.54% decrease from 2024.
- Eton Pharmaceuticals Inc. annual ebitda for 2024 was -1.5 M, a 398.63% increase from 2023.
- Eton Pharmaceuticals Inc. annual ebitda for 2023 was -291000, a 96.45% decrease from 2022.
- Eton Pharmaceuticals Inc. annual ebitda for 2022 was -8.2 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Eton Pharmaceuticals Inc. EBITDA — FAQ
Eton Pharmaceuticals Inc. (ETON) ebitda over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ETON's ebitda history?
The chart and table above show Eton Pharmaceuticals Inc.'s ebitda by year and by quarter, including the growth rate.